• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND CO. SYRINGE 10ML REG PR SALINE FILL SPKG; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND CO. SYRINGE 10ML REG PR SALINE FILL SPKG; INTRAVASCULAR CATHETER Back to Search Results
Model Number 306553
Device Problem Packaging Problem (3007)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/08/2020
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that syringe 10ml reg pr saline fill spkg had watermarking in the box.The following information was provided by the initial reporter: "material no: 306553 batch no: 9011582 it was reported that stains were noticed inside the packaging.Event description per attached email states: supposed to be a sterile syringe but has stains inside the package.Date received for intake: 13-apr-2020".
 
Manufacturer Narrative
The following fields were updated due to additional information: d.10.Device available for eval?: yes.Returned to manufacturer on: 4/27/2020.Investigation: a device history record review was performed for provided lot number 9011582 and the review did not reveal any detected quality issues during the production process that could have contributed to this reported incident.To aid in the investigation of this issue, a physical sample was provided for evaluation by our quality engineer team.Through examination of the sample, foreign matter was observed on the product packaging.It has been determined that this incident resulted during the steam sterilization process.The integrity of the product and the sterile barriers have not been affected.Furthermore, microbial permeability testing, cytotoxicity testing, and testing for residual solvents and volatile species has been completed on the packages displaying the brownish stain.The testing confirmed that they do not present any risk to the use of the product and have no impact on the effectiveness, sterility, quality or safety of bd posiflush¿ sf 10ml saline flush syringe.
 
Event Description
It was reported that syringe 10ml reg pr saline fill spkg had watermarking in the box.The following information was provided by the initial reporter: "material no: 306553 batch no: 9011582.It was reported that stains were noticed inside the packaging.Event description per attached email states: supposed to be a sterile syringe but has stains inside the package.Date received for intake: 13-apr-2020.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYRINGE 10ML REG PR SALINE FILL SPKG
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON, DICKINSON AND CO.
donore road
drogheda
MDR Report Key10022726
MDR Text Key204247562
Report Number9616657-2020-00068
Device Sequence Number1
Product Code NGT
UDI-Device Identifier30382903065531
UDI-Public30382903065531
Combination Product (y/n)N
PMA/PMN Number
K153481
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 05/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/04/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date12/31/2021
Device Model Number306553
Device Catalogue Number306553
Device Lot Number9011582
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/27/2020
Date Manufacturer Received04/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-